Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-16-112357
Filing Date
2016-07-11
Accepted
2016-07-11 10:14:26
Documents
4
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v443958_10ka.htm 10-K/A 41842
2 EXHIBIT 10.85 v443958_ex10-85.htm EX-10.85 88442
3 EXHIBIT 31.1 v443958_ex31-1.htm EX-31.1 3743
4 EXHIBIT 31.2 v443958_ex31-2.htm EX-31.2 3627
  Complete submission text file 0001144204-16-112357.txt   138741
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-15697 | Film No.: 161760933
SIC: 2834 Pharmaceutical Preparations